chrisvoncsefalvay/vaers-outcomes huggingface dataset:
detailed below.     The patient's past medical history included Flu vaccination in 2020.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 21-Jan-2021, the patient experienced VACCINATION SITE MASS (felt like it was lumpy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Arm in the area of the injection site became red/redness migrated toward my elbow) and VACCINATION SITE PAIN (painful). On an unknown date, the patient experienced FEELING ABNORMAL (feels slightly uncomfortable). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Itching, at an unspecified dose and frequency. On 16-Jan-2021, PAIN IN EXTREMITY (Arm was sore) had resolved. On 25-Jan-2021, VACCINATION SITE MASS (felt like it was lumpy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Arm in the area of the injection site became red/redness migrated toward my elbow) and VACCINATION SITE PAIN (painful) had resolved. At the time of the report, FEELING ABNORMAL (feels slightly uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Breakthrough case admission after 3 vaccines Pfizer 2/9/21 Lot# El9269;   Pfizer 3/2/21 Lot# EN6202; PFizer 10/19/21 loT# FF2590
initially numbness of right arm reported on day of second vaccine. noted to have muscle aches and pains on day one after second vaccine dose. two days after vaccine, was complaining of severe chest pain, so was taken to ED.
Patient was given 2nd bivalent booster dose. correct previous dose date and shot sequence number was then discovered. No symptoms or issues arose during 15 min observation period. We will contact patients primary care physician.
Received H1N1 at school. To office with localized reaction to chest, back and arm. BENADRYL po given. Discharged with father.
PSORIATIC ARTHRITIS FLARE UP AFTER COVID-19 VACCINE; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included ear infection with humira (adalimumab). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular) dose was not reported, 1 total administered on an unspecified date in MAY-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date in MAY-2021, the patient experienced psoriatic arthritis flare up after covid-19 vaccine. Treatment medications included adalimumab. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from psoriatic arthritis flare up after covid-19 vaccine on 2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210601327-covid-19 vaccine ad26.cov2.s- psoriatic arthritis flare up  after covid-19 vaccine. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Patient is an 80 y/o woman with a PMHx of Afib, CAD, HTN, PVD, OSA, COPD, GERD, and anxiety/depression. She presented to the ED c/o sore throat, cough, nasal congestion, shortness of breath, fatigue, decreased appetite, malaise, nausea, diarrhea, and headache over the past 6 days. Her husband was diagnosed with COVID about 9 days ago and she developed sx 3 days later. They were both given paxlovid but were unable to tolerate due to taste. She has received COVID vaccine and booster. She denies fever or chills. She has been generally weak and fatigued. Due to no improvement in her symptoms she presented to the ED for evaluation.  In the ED she has been hypertensive around 170/61. Afebrile. RA ABG with pH 7.38, pCn the ED she has been hypertensive around 170/61. Afebrile. RA ABG with pH 7.38, pCO2 45, pO2 54, O2 sat 87. She was placed on 2L O2 via NC with improvement in O2 sat. At baseline she wears O2 at night with her CPAP. She does not require oxygen during the day on a regular basis. Labs with WBC 8.14, Hgb 13.8, Na 139, K 3.8, BUN 12.4, Cr 0.8, glucose 114. COVID positive. CXR with no acute airspace disease. Hospitalist service contacted for admission.    Patient discharged home with family on 6/5/2022.
The primary reporter is a Field Representative. The representative was told by the RN (whow as also the patient) that he completed his treatment regimen with RECOMBIVAX and "did not show any evidence of vaccination on titer after completing the regiment".
Acute onset (within minutes) pain, swelling, headache, flush. Treated with Benadryl IM, Phenergan, Motrin.
This spontaneous report was received from a registered nurse refers to an unspecified patients of unknown age and gender. No pertinent medical history was reported. On an unknown dates, the patients were vaccinated with doses of improperly stored LIQUID PEDVAXHIB (lot # K008879 and expiration date 30-MAR-2017) (dose and route were not reported). No adverse effects were reported. This is one of the several reports received from the same source. Additional information has been requested.
Strong headache; Fever; Body aches; Joint aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Strong headache), PYREXIA (Fever), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and CHILLS (Chills) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 006C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Allergy (sneezing, runny nose). Concomitant products included LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced HEADACHE (Strong headache), PYREXIA (Fever), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and CHILLS (Chills). At the time of the report, HEADACHE (Strong headache), PYREXIA (Fever), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and CHILLS (Chills) outcome was unknown.            Concomitant medication included high blood pressure medication.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Vaccine given in gluteus instead of deltoid.Vaccine given in gluteus instead of deltoid.
Patient states that 2 days after shingles vaccination that he experienced a rash redness, as well a a fever of over 100 degrees along with chills and joint pain. It only lasted 24 hours.
Sore throat, runny nose, head ache, fatigue, coughing, nausea, diarrhea, chills with shaking. Symptoms started 3 days post, improving but still present.
COVID-19 breakthrough infection; COVID-19 breakthrough infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 37-year-old male patient received BNT162b2 (BNT162B2), on 13Mar2021 as dose 1, single (Batch/Lot number: unknown) and on 05Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 13Nov2021 as dose 3 (booster), single (Lot number: 051F21A) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "recovered" and all described as "COVID-19 breakthrough infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After the second dose, I had moderate body aches, headaches, fatigue.  These symptoms lasted about 3 days.  The injection site area on my left arm was really achy for 4 days.  I did not do any special treatment other than getting in a nap to get rest.  The symptoms went away on its own, and I did not report these symptoms to my doctor or to VAERS since these were the typical symptoms already well known at the time.  I did also have some pain in my left armpit after the 2nd shot, but I did not attribute this symptom to the vaccine since I've had this left armpit pain on and off for about 7 months prior to the second vaccine shot.  The pain level I felt after the vaccine was not any worse than what I had felt prior to covid vaccination.    After the third dose (booster shoot), I had mild headaches on and off starting around 3 hours after receiving the shot.  This lasted through the fourth day (today) and still continuing.  On the 2nd day, I started to have mild body aches that lasted a little over a day.  The injection site on my left arm was also achy for 3 days (but milder than after the second shot).   The left armpit pain came back, starting around the second day, and the pain is much worse than I had ever felt in the past (even when compared to pre-covid-vaccination days).  The pain is continuous (not on and off like the headache).  I did not pay much attention to the pain though until last night (end of day 3) when I took a look in the mirror.  I saw that my left armpit was very noticeably swollen compared to my right armpit.  Earlier in the day (on day 3),  the pain got worse than day 2, and I started to notice that the left armpit area would do small jiggles / wobble if I walk with my left elbow lifted out about 45 degrees.  After seeing the swelling that night, I can see why I felt that jiggling.  The left armpit pain is worse enough where I cannot sleep on either side.   If I laid down on my left side, the injection site area on the left arm as well as the armpit would hurt to an uncomfortable level.  If I laid down on my right side, the weight of my left arm pressing downwards from gravity creates pain to an uncomfortable level as well.  The left armpit pain also makes it harder and slower for me to get dressed, reach for my car's seatbelt, or to even let my left arm hang straight down when I stand or walk.  I have been tilting my left elbow out a bit during the day to avoid putting pressure to the swollen armpit. Today, on day 4, the left armpit swelling and pain is still continuing, but a little less than at the end of day 3 yesterday.
Patient took FLUMIST approx 5:30pm on 11-23-09 by 6:00pm patient was at ER c/o itching, hives, swelling of tongue, difficulty breathing. Stayed in ER approx. 5 hours and released. spoke to the reporter to confirm that the urticaria was located on the "arms and chest" and I confirmed that she indeed had tongue swelling.
pt c/o ascending leg & back pain & weakness of legs, diff in climbing stairs-sx started evening of 5DEC97 & inc through the noc;taken to ER for eval 6DEC97;pt had been treated URI 4DEC97 in ofc & had vax 20NOV97;tx for poss GBS;
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 13-NOV-2017, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB (dose, frequency and route of administration were not reported) lot # N001348 and expiration date: 31-OCT-2019. No adverse effects were reported. On 08-NOV-2017, the LIQUID PEDVAXHIB was stored in between 47 Fahrenheit degrees to 77 Fahrenheit degrees for 45 minutes. There was no previous temperature excursions. The digital data logger was involved in recording the temperature excursion. This is one of five reports received from the same reporter.; Sender's Comments: US-009507513-1711USA006084: US-009507513-1711USA006682: US-009507513-1711USA006683: US-009507513-1711USA006685:
The patient fainted shortly after the vaccine. Patient stated that this has happened twice in the past with other vaccinations. He feels this had nothing to do with the vaccination its self.
3 days after first shot in right arm rash developed on upper arm; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), 3 days after the suspect product(s) administration, outcome "unknown", described as "3 days after first shot in right arm rash developed on upper arm".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Extreme tiredess within 1 hour of vaccine.  Within 2 hours of vaccine, headache and fever of 103 degrees F.  Fever and headache reduced by Motrin (300 mg, 3 children's chewable), but would reoccur as soon as Motrin wore off.  42 hours after vaccine, fever minimal, but headache continues.  Pt. bedridden with tiredness, fever, headaches.
Patient received Varicella vaccine 2 days prior to MMR.  Did not disclose to HCP.
Large hives on whole body. Benadryl given for 5 days. No other symptoms or respiratory distress.
Rotavirus vaccine was administered IM instead of orally. The pt did not experience any adverse events.
Stomach pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain) and CHILLS (Chills) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.  No Medical History information was reported.  On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and CHILLS (Chills). At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain) and CHILLS (Chills) had resolved.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.  No concomitant medication information was reported. No treatment medication information was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
100.2 degree fever, body aches, chills, fatigue; lasted 24 hours Pain in injected arm for three days; difficult to raise or move arm
I did not get a period from 11/2021 - 4/2022. I also had a strange rash that formed on the palm of my right hand.  Time frame was the same.
severe headache; body aches; This is a spontaneous report from a contactable physician. A 17-year-old male patient received meningococcal group b rlp2086 (TRUMENBA) (lot# CN8296), via an unspecified route of administration, on 26Aug2020, at single dose, for immunisation. Medical history and concomitant medications were none. The patient experienced severe headache and body aches both on 26Aug2020 within hours from vaccination. Therapeutic measures were taken as a result of the events and included treatment with Advil and Benadryl. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020287180 same reporter/drug, different patient/event
Sore arm for two days, loss of appetite. Weeks with decreased appetite. Not feeling hungry majority of the time. Feeling like you want to eat but don?t have an appetite for anything and don?t get hungry or hunger pangs.
Client received flu vaccine. Patient complain of burning feeling. Told patient that is most likely the medicine, and to stay the 15 minutes. PATIENT WAITED AROUND. patient left to clock out for lunch, but felt lightheaded. Patient came back to room. Patient was laid down on floor with legs elevated. Patient pulse was 88 bpm and no signs of respiratory distress. Patient complain of tightness in chest and throat area. Cool towel was given. Patient was still 88 bpm 15 minutes later. Patient complain of a tingling in her tongue with the tightness in chest. Husband stated that his wife has a past history of panic attacks. Patient not in medication. Gave 0.2 Epi SC to patient. Pulse was 96 bpm 5 minutes later patient stated that her chest felt better. Continue to watch patient for 30 minutes, and she still didn't feel right. Patient call her doctor office left message to call me back. The nurse called back, and I spoke with her and told her patients symptoms. The nurse advised for patient to go to ER. Husband took patient to ER. Reported this.
Severe intermittent arthralgia; Body and head aches; Body and head aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L02A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches). At the time of the report, ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. After the second dose of the Moderna Covid vaccine He started experiencing severe intermittent arthralgia that caused him a lot of difficulties on his daily life. He is under medical treatment. Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Father reported to public health nurse at 0820 am 2/19/04 patient is complaining of feeling dizzy and just wants to stay in bed. Unable to get up and go to school which isn't like her. Instructed to go to primary medical doctor for evaluation this A.M.
pt recv vax;rash, itching, fatigue, onset 2 hr p/ vax;
Got shot on 5/21/21 started getting concerned June 11th due to continuous soreness, numbness to fingers, not being able to raise arm pass my shoulders and losing sleep cause I lay on my arm which woke me up continuously.
abnormal liver function tests; G-glutamyl Transpeptidase 104 (nl 0-94); SPG Transaminase 95 (nl 1-60);
Body covered in rashes, mild. Read, itchy, not warm, from top of my head to toes
I woke up yesterday with a large, red, itchy, burning ring around the vaccine injection site and a red rash on both lower arms and a spot on my face. I also had pain down my arm and into my hand like with other vaccines I've had.
Patient received immunizations at 6 months DTaP, Prevnar vaccine. Had uneventful day and night. Mom, during night, heard sound of heavy breathing. Went to check on baby and color was blue and limp. Parent gave mouth to mouth and infant responded after several minutes. Patient transported by ambulance to ER; seen and evaluated and placed on apneic monitor.
Narrative: Patient was administered second dose of Covid Vaccine on June 3, 2021 and was observed for 15 minutes afterwards without any issues. At Primary Care appointment on December 1, 2021 he reported he experienced generalized aches and pains after receiving the vaccine.
End of February I was in the hospital with heart complications and I didn't know if it was related to the vaccine or not. I followed up with my PCP and they determined that I had high blood pressure. At the time I stopped my hormone therapy and thought that my symptoms may have been related to that. I do have a family history of heart complication, so I am just unsure if this was related to the vaccine or not.
My blood sugar levels were unusually high for a one and a half week period. After that happened, I knew about it because I'm on the Dexcom G6 system which gives you readings every 5 minutes through a wearable transmitter and sensor. I was able to look at that and it was never high for me, then this happened for a week and a half and then it stopped. You typically fluctuate back and forth normally, but in this case, it was about 250-300 which is way high for me. At one point, there was one 400 reading that was only for a few minutes. Usually, my readings are at about 170. after about a week and a half or so, and during this time I was taking my supervised insulin shots (I do my own shots but supervised by endocrinologists) so I knew it was high, then all of a sudden it just dropped to normal. Within that time period it fluctuated but at a higher level than what was normal on the graph. Since that time, that only happened for about a week and a half and they came back to normal.
This spontaneous report as received from a nurse to a patient of unknown age. On 14-JUN-2014, the patient was vaccinated with a booster dose of VARIVAX lot# H011233, expiration date 12-JUN-2014 (also reported as 06-JUN-2014), 2 days after expiration date, for unknown indication. On an unknown date in April 2003, patient was vaccinated with VARIVAX, 0.5 ml (milliliter), subcutaneous, for unknown indication. No concomitants were reported. No adverse effects reported. No product quality complaint (PQC) was involved. The outcome of events was unknown. No additional information provided. Additional information has been requested.
01/07/21 tingling and numbness in whole right arm right after vaccine administration 01/08/21 woke up about 230am with severe body aches (flu like) and severe arm pain not just soreness where vaccine was given but whole upper arm that lasted all day and went on for almost two whole days
This patient received the flu shot on 12/20/00. No elevated discomfort at the time of the injection. Within 24 hours, the patient experienced alot of discomfort in the deltoid to elbow region. Discomfort limits range of motion at times. The patient did not have fever at anytime, but discomfort persists. The patient took Tylenol one time with some measure of relief. No redness or induration noted  at the left deltoid area. The patient referred to the PMD for evaluation.